Skip to main content
. 2011 Nov 2;37(3):838–849. doi: 10.1038/npp.2011.264

Table 1. Demographic and Clinical Characteristics of Study Participants.

  Control group (N=47) LOD group (N=48) P-value
Age (years±SD) 70.7±4.37 71.8±4.8 NS
Education (years±SD) 9.2±4.8 9.3±4.2 NS
Sex (M/F) 9/38 12/36 NS
Duration of illness (years±SD) 0 1.3±0.5 <0.0001
HAM-D17 total score (SD) 1.9±1.9 18.9±6.5 <0.0001
       
CERAD-K battery (SD)
 VF 13.3±2.9 12.3±3.7 NS
 BNT 11.3±2.1 9.3±2.4 <0.0001
 MMSE 28.1±11. 27.1±1.0 0.001
 WLM 18.2±3.5 14.6±4.0 <0.0001
 CP 9.4±1.5 8.1±1.9 NS
 WLR 6.4±1.9 4.3±1.8 <0.0001
 WLRc 9.3±1.0 8.1±1.9 <0.0001
 CR 6.7±2.9 4.8±3.0 0.003
Stroop test reaction time (seconds±SD) 30.2±5.7 42.1±16.8 0.003
Stroop test error (SD) 1.5±1.4 2.5±2.6 NS
Hypertensiona, n (%) 5 (10.6) 6 (12.5) NS
Diabetesb, n (%) 3 (6.4) 2 (4.1) NS
Dyslipidemiac, n (%) 2 (4.1) 1 (2.1) NS
Stroke or TIA, n (%) 0 0 NS
History of heart disease, n (%) 0 0 NS
Current smokers, n (%) 0 0 NS
History of smoking, n (%) 0 0 NS
Antihypertensive agents, n (%) 5 (10.6) 6 (12.5) NS
Hypoglycemic agents, n (%) 3 (6.4) 1 (2.1) NS
Lipid-lowering agents, n (%) 2 (4.1) 1 (2.1) NS
Body mass index (kg/m2±SD) 24.2±3.9 23.7±4.1 NS
Systolic blood pressure (mm Hg±SD) 128.2±7.3 127.5±8.1 NS
Diastolic blood pressure (mm Hg±SD) 83.4±8.7 82.3±7.4 NS
Total cholesterol (mg/dl±SD) 170.8±23.4 169.9±25.1 NS
High-density lipoprotein (mg/dl±SD) 58.5±13.2 59.7±12.5 NS
Triglycerides (mg/dl±SD) 103.2±14.9 104.3±13.7 NS
Glucose (mg/dl±SD) 98.9±5.7 97.3±7.4 NS

Abbreviations: LOD, late-onset depression; NS, statistically not significant; HAM-D17, 17-item Hamilton Depression Rating Scale; CERAD-K, the Korean version of Consortium to Establish a Registry for Alzheimer's Disease; VF, Verbal Fluency; BNT, 15-item Boston Naming Test; MMSE, Mini Mental Status Examination; WLM, Word List Memory; CP, Constructional Praxis; WLR, Word List Recall; WLRc, Word List Recognition; CR, Constructional Recall; TIA, transient ischemic attack.

a

Hypertension defined according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) (Chobanian et al, 2003).

b

Diabetes mellitus defined according to International Diabetes Federation Epidemiology Task Force Consensus Group (Alberti et al, 2005).

c

Dyslipidemia defined according to Revised The National Cholesterol Education Program Adult Treatment Panel III criteria (NCEP ATP III) (Grundy et al, 2005.